How to Use Weight Loss Injections Safely and Effectively

Choosing where to inject, and why rotation matters

The three approved sites for subcutaneous injection are the abdomen (at least 5 cm from the navel), the front or outer thigh, and the upper arm. All three work; which you choose on any given week is largely personal preference. What matters more is not repeating the same spot. Injecting into the same small patch repeatedly can cause lipohypertrophy, a hardening of the tissue that slows absorption and can make the injection sting more. A simple rotation pattern (left thigh one week, abdomen the next, right thigh the week after) keeps things predictable without much thought.

Pinching a fold of skin lightly before injecting helps if you are lean in that area, but most people find that pressing the pen firmly against the skin and activating it is enough. The needles on these pre-filled pens are very short (typically 4–8 mm) so the technique is far less daunting than it sounds. Our step-by-step injection guide walks through the full process if you want more detail on position and pen activation.

Cleaning the site beforehand is good practice. Alcohol swabs are an inexpensive way to keep this part of the routine consistent, and used needles and pens should go into a proper sharps container, not the household bin.

Storage, routine and what to do when life gets in the way

Both Mounjaro and Wegovy pens are stored in the fridge at 2–8°C until you start using them. Once out of the fridge, a limited time at room temperature is permitted, the exact window differs between products, so the figure to follow is the one printed in your Patient Information Leaflet, not a number from a forum. A practical tip: many people keep their current pen in the fridge door next to everyday items, which doubles as a visual reminder that the injection day is coming.

Weekly injections are easiest to maintain when tied to the same day each week. If a dose is missed or you are unsure whether to change days, your prescriber and the Patient Information Leaflet are the right places to turn, not a general guide like this one, because the answer can depend on how long since your last dose and where you are in your titration schedule.

For a broader picture of how often these injections are given and what the schedule looks like over time, our page on injection frequency covers that clearly. Questions about how long treatment typically continues are answered on our page about duration of weight loss injections.

Managing side effects, what is normal and what needs attention

The most frequently reported side effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and burping. These are most pronounced in the first week or two after starting or after a dose increase, and they tend to settle as your system adapts. Eating smaller meals, staying well hydrated, avoiding very fatty or spicy food, and not lying down immediately after eating all help. Fatigue, mild headache, and injection-site redness are also reported and usually short-lived.

The NHS guidance on tirzepatide provides a thorough breakdown of what to expect, and is worth reading alongside your Patient Information Leaflet. There are symptoms that need prompt medical attention. Severe, persistent abdominal pain that radiates to the back (with or without vomiting) can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update issued in January 2026 for all GLP-1 medicines. Call NHS 111 or go to A&E if that symptom appears. Signs of a serious allergic reaction, significant dehydration from prolonged vomiting or diarrhoea, or sudden changes to vision also warrant urgent review.

You can report any suspected side effect through the MHRA Yellow Card scheme, which helps regulators monitor medicine safety in real-world use.

What affects whether you can use weight loss injections at all

Not everyone is a candidate. The licensed criteria for Mounjaro cover adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea, lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Semaglutide (Wegovy) carries similar criteria. Neither is licensed for anyone under 18, and neither is recommended during pregnancy, while breastfeeding, or when trying to conceive.

Certain medical histories require careful prescriber review: a personal or family history of medullary thyroid carcinoma, MEN2, previous pancreatitis, or specific gastrointestinal conditions all feature in the safety assessment. The prescriber's job is to weigh all of this for your situation, BMI alone is never the whole picture. Our page on who can use weight loss injections sets out the eligibility detail clearly, and our weight loss injection overview explains how each medicine works and the differences between them.

If you are researching cost alongside these practical questions, our page on the real cost of weight loss injections in the UK addresses what those headline prices typically do and do not include. For the full picture of treatment options, the weight loss treatments page is the place to start a consultation with our prescribers.